Cannon Advisors Inc. Purchases 196 Shares of Agilent Technologies, Inc. (NYSE:A)

Cannon Advisors Inc. lifted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 6.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,026 shares of the medical research company’s stock after purchasing an additional 196 shares during the period. Cannon Advisors Inc.’s holdings in Agilent Technologies were worth $407,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. CKW Financial Group increased its holdings in Agilent Technologies by 114.9% in the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 100 shares during the period. Global X Japan Co. Ltd. grew its position in shares of Agilent Technologies by 161.1% in the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock valued at $25,000 after buying an additional 116 shares during the last quarter. Lee Danner & Bass Inc. acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at about $29,000. Hanson & Doremus Investment Management raised its position in shares of Agilent Technologies by 66.5% during the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock worth $35,000 after acquiring an additional 105 shares during the last quarter. Finally, OFI Invest Asset Management acquired a new position in shares of Agilent Technologies in the fourth quarter worth approximately $37,000.

Analyst Upgrades and Downgrades

A has been the subject of a number of recent analyst reports. Bank of America decreased their target price on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a research report on Friday, December 13th. Wells Fargo & Company decreased their price objective on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research report on Monday, December 9th. Citigroup boosted their target price on shares of Agilent Technologies to $165.00 and gave the company a “buy” rating in a report on Thursday, December 19th. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Finally, Barclays raised Agilent Technologies from an “underweight” rating to an “equal weight” rating and boosted their price objective for the company from $135.00 to $145.00 in a research note on Monday, February 10th. Seven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $150.83.

Agilent Technologies Trading Up 0.3 %

NYSE A opened at $116.99 on Tuesday. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. Agilent Technologies, Inc. has a 52 week low of $113.76 and a 52 week high of $155.35. The business has a 50 day moving average price of $133.68 and a 200-day moving average price of $136.49. The company has a market cap of $33.35 billion, a price-to-earnings ratio of 26.89, a P/E/G ratio of 3.27 and a beta of 1.11.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. The business had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. As a group, equities analysts expect that Agilent Technologies, Inc. will post 5.57 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be given a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.99 annualized dividend and a yield of 0.85%. Agilent Technologies’s payout ratio is 22.76%.

Insider Buying and Selling at Agilent Technologies

In other news, VP Rodney Gonsalves sold 1,908 shares of the company’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the sale, the vice president now owns 21,786 shares in the company, valued at $2,657,456.28. This represents a 8.05 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Padraig Mcdonnell sold 1,911 shares of the firm’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the transaction, the chief executive officer now directly owns 39,652 shares in the company, valued at $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The disclosure for this sale can be found here.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.